In last trading session, Atyr Pharma Inc (NASDAQ:ATYR) saw 2.01 million shares changing hands with its beta currently measuring 0.76. Company’s recent per share price level of $3.03 trading at -$0.28 or -8.46% at ring of the bell on the day assigns it a market valuation of $269.68M. That closing price of ATYR’s stock is at a discount of -53.8% from its 52-week high price of $4.66 and is indicating a premium of 53.14% from its 52-week low price of $1.42. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.22 million shares which gives us an average trading volume of 1.53 million if we extend that period to 3-months.

Atyr Pharma Inc (NASDAQ:ATYR) trade information

Upright in the red during last session for losing -8.46%, in the last five days ATYR remained trading in the red while hitting it’s week-highest on Monday, 05/12/25 when the stock touched $3.03 price level, adding 12.68% to its value on the day. Atyr Pharma Inc’s shares saw a change of -16.30% in year-to-date performance and have moved -4.11% in past 5-day. Atyr Pharma Inc (NASDAQ:ATYR) showed a performance of 0.66% in past 30-days. Number of shares sold short was 10.03 million shares which calculate 7.01 days to cover the short interests.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 34.28% during past 5 years.

Atyr Pharma Inc (NASDAQ:ATYR)’s Major holders

Insiders are in possession of 2.24% of company’s total shares while institution are holding 62.27 percent of that, with stock having share float percentage of 63.70%. Investors also watch the number of corporate investors in a company very closely, which is 62.27% institutions for Atyr Pharma Inc that are currently holding shares of the company.

On the other hand, Federated Hermes Equity Funds-Federated Hermes Kaufmann Fund and Federated Hermes Equity Funds-Federated Hermes Kaufmann Small Cap Fund are the top two Mutual Funds which own company’s shares. As of Jan 31, 2025 , the former fund manager was holding 7.85 shares of worth $23.79 million or 8.82% of the total outstanding shares. The later fund manager was in possession of 6.62 shares on Jan 31, 2025 , making its stake of worth around $20.06 million in the company or a holder of 7.44% of company’s stock.